Hijacking the Blimp1-Neuritin Axis to Promote Cancer by Follicular Regulatory T-cells
劫持 Blimp1-Neuritin 轴通过滤泡调节 T 细胞促进癌症
基本信息
- 批准号:10629053
- 负责人:
- 金额:$ 20.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAdoptive TransferAreaAutonomic DysfunctionAutonomic nervous systemBiological AssayCancer PatientCellsFOXP3 geneFosteringFrequenciesGoalsHormonesHumanImmuneImmune EvasionImmune systemImmunofluorescence ImmunologicImmunotherapeutic agentIn VitroInfiltrationInvestigationLocationMalignant - descriptorMalignant NeoplasmsModelingMusNatureNeoplasm MetastasisNerveNerve FibersPRDM1 genePeripheralPeripheral NervesPsychological StressRegulationRegulatory T-LymphocyteReportingResearchRiskRoleStainsTestingTissuesTumor ImmunityTumor PromotionTumor-Infiltrating LymphocytesTumor-associated macrophagesanticancer researchaxonal sproutinggenetic signaturein vivoinnovationinsightnerve supplyneurofilamentneuroregulationneurotrophic factorpatient prognosisreconstitutionresponseretroviral-mediatedtherapy resistanttranscription factortumortumor growthtumor microenvironmenttumor progressiontumor-immune system interactionstumorigenesis
项目摘要
Project Summary
Recent studies have highlighted the vital role of nerves infiltrating the tumor microenvironment (TME) in
tumorigenesis and caner progression. The current research in this field is largely focused on the impact of
dysfunctions of autonomic nervous system or psychological stress-induced hormone network on the malignant
progression of cancer. The potential regulation of peripheral nerve system by immune cells in the TME, which
subsequently influences tumorigenesis, has not been extensively studied. The overall goal of this proposal is to
define how a specific Treg subset, called follicular regulatory T (TFR) cells, modulates the TME to promote cancer
by producing and utilizing a neurotrophic factor, which is an unexplored area in the field of cancer research. We
have recently reported the pro-tumoral activity of TFR cells, which depends on the expression of the transcription
factor Blimp1 (encoded by Prdm1). Further analysis revealed that higher tumoral TFR signatures along with
PRDM1 expression indicated increased malignancy and risk of metastasis in many cancers. Moreover,
intratumoral TFR cells compared to conventional Treg cells and their peripheral counterparts expressed higher
levels of neuritin (encoded by Nrn1), a neurotrophic factor implicated in tumorigenesis, while its mechanistic
action remains largely unclear. Notably, TFR signature and PRDM1 positively correlated with NRN1 expression
in cancer patients. Intratumoral TFR cells in mice with disrupted TFR suppression due to Foxp3-specific deletion
of Blimp1 had substantially reduced expression of neuritin. Most importantly, tumors from these mice and mice
lacking TFR cells had markedly reduced neurofilament accumulation compared to wild-type tumors, and
intratumoral TFR cells were enriched with gene signatures implicated in axonogenesis. We propose to define the
mechanisms by which TFR cells exploit the Blimp1-neuritin axis to regulate the TME and tumor progression, and
to define the capacity of TFR-derived neuritin in promoting axonogenesis in the tumor. Findings obtained here will
revolutionize our understanding of the tumor innervation and immunosuppressive TME, aiding in developing new
immunotherapeutic approaches to treat cancer.
项目概要
最近的研究强调了神经浸润肿瘤微环境(TME)在
肿瘤发生和癌症进展。目前该领域的研究主要集中在
自主神经系统或心理应激诱发的激素网络功能障碍对恶性疾病的影响
癌症的进展。 TME 中免疫细胞对周围神经系统的潜在调节,
随后影响肿瘤发生,尚未得到广泛研究。该提案的总体目标是
定义特定的 Treg 子集(称为滤泡调节 T (TFR) 细胞)如何调节 TME 促进癌症
通过产生和利用神经营养因子,这是癌症研究领域中尚未探索的领域。我们
最近报道了 TFR 细胞的促肿瘤活性,这取决于转录的表达
因子 Blimp1(由 Prdm1 编码)。进一步分析表明,较高的肿瘤 TFR 特征以及
PRDM1 表达表明许多癌症的恶性程度和转移风险增加。而且,
与传统 Treg 细胞及其外周细胞相比,瘤内 TFR 细胞表达更高
神经突蛋白(由 Nrn1 编码)的水平,这是一种与肿瘤发生有关的神经营养因子,而其机制
行动在很大程度上仍不清楚。值得注意的是,TFR 特征和 PRDM1 与 NRN1 表达呈正相关
在癌症患者中。由于 Foxp3 特异性缺失,TFR 抑制受到破坏的小鼠肿瘤内 TFR 细胞
Blimp1 的表达显着降低了神经突蛋白的表达。最重要的是,来自这些小鼠和小鼠的肿瘤
与野生型肿瘤相比,缺乏 TFR 细胞的神经丝积累显着减少,并且
瘤内 TFR 细胞富含与轴突发生有关的基因特征。我们建议定义
TFR 细胞利用 Blimp1-neuritin 轴调节 TME 和肿瘤进展的机制,以及
确定 TFR 衍生的神经突蛋白促进肿瘤轴突发生的能力。此处获得的调查结果将
彻底改变我们对肿瘤神经支配和免疫抑制 TME 的理解,有助于开发新的
治疗癌症的免疫治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jianmei Wu Leavenworth其他文献
Jianmei Wu Leavenworth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jianmei Wu Leavenworth', 18)}}的其他基金
Contribution of the effector Treg-B-antibody nexus to the regulation of CNS autoimmunity
效应 Treg-B-抗体关系对中枢神经系统自身免疫调节的贡献
- 批准号:
10837917 - 财政年份:2020
- 资助金额:
$ 20.83万 - 项目类别:
Contribution of the effector Treg-B-antibody nexus to the regulation of CNS autoimmunity
效应 Treg-B-抗体关系对中枢神经系统自身免疫调节的贡献
- 批准号:
10621378 - 财政年份:2020
- 资助金额:
$ 20.83万 - 项目类别:
Contribution of the effector Treg-B-antibody nexus to the regulation of CNS autoimmunity
效应 Treg-B-抗体关系对中枢神经系统自身免疫调节的贡献
- 批准号:
10404044 - 财政年份:2020
- 资助金额:
$ 20.83万 - 项目类别:
Contribution of the effector Treg-B-antibody nexus to the regulation of CNS autoimmunity
效应 Treg-B-抗体关系对中枢神经系统自身免疫调节的贡献
- 批准号:
10804754 - 财政年份:2020
- 资助金额:
$ 20.83万 - 项目类别:
相似海外基金
Control of Regulatory T Cell Function by Toll-Like Receptor 7
Toll 样受体 7 对调节性 T 细胞功能的控制
- 批准号:
10438923 - 财政年份:2021
- 资助金额:
$ 20.83万 - 项目类别:
Control of Regulatory T Cell Function by Toll-Like Receptor 7
Toll 样受体 7 对调节性 T 细胞功能的控制
- 批准号:
10650735 - 财政年份:2021
- 资助金额:
$ 20.83万 - 项目类别:
Control of Regulatory T Cell Function by Toll-Like Receptor 7
Toll 样受体 7 对调节性 T 细胞功能的控制
- 批准号:
10304769 - 财政年份:2021
- 资助金额:
$ 20.83万 - 项目类别:
Targeting Radiation-Induced Myeloid Cells to Promote T cell Immunity in Undifferentiated Pleomorphic Sarcoma
靶向放射诱导的骨髓细胞促进未分化多形性肉瘤中的 T 细胞免疫
- 批准号:
10159221 - 财政年份:2020
- 资助金额:
$ 20.83万 - 项目类别:
Targeting Radiation-Induced Myeloid Cells to Promote T cell Immunity in Undifferentiated Pleomorphic Sarcoma
靶向放射诱导的骨髓细胞促进未分化多形性肉瘤中的 T 细胞免疫
- 批准号:
10443586 - 财政年份:2020
- 资助金额:
$ 20.83万 - 项目类别: